Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Depreciation & Amortization (CF) (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Depreciation & Amortization (CF) data on record, last reported at -$12000.0 in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 125.53% year-over-year to -$12000.0; the TTM value through Dec 2025 reached $100000.0, down 72.07%, while the annual FY2025 figure was $100000.0, 72.07% down from the prior year.
  • Depreciation & Amortization (CF) reached -$12000.0 in Q4 2025 per PRAX's latest filing, down from $19000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $119000.0 in Q2 2022 and bottomed at -$12000.0 in Q4 2025.
  • Average Depreciation & Amortization (CF) over 4 years is $78625.0, with a median of $92500.0 recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): grew 13.98% in 2023, then crashed 125.53% in 2025.
  • A 4-year view of Depreciation & Amortization (CF) shows it stood at $86000.0 in 2022, then dropped by 8.14% to $79000.0 in 2023, then crashed by 40.51% to $47000.0 in 2024, then plummeted by 125.53% to -$12000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were -$12000.0 in Q4 2025, $19000.0 in Q3 2025, and $46000.0 in Q2 2025.